Browse the detailed record of transactions filed by Bilinsky Igor, 首席运营官. Officer active across 2 companies, notably Iovance Biotherapeutics, INC.. Cumulatively, 29 disclosures have been logged. Activity tracked since 14 June 2022. The latest transaction was filed on 1 September 2026 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Bilinsky Igor
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
BILINSKY IGOR is Chief Operating Officer. He has 27 filings in total, all within the recent filing sample covered, mainly at Iovance Biotherapeutics, INC. and, earlier, at Ignyta, Inc., with the transaction nature most often shown as option exercise. In this recent sample, the buy and sell amounts are 0 and 0, and the period runs from 2016-01-11 to 2026-06-09.